Retrophin management update

Retrophin Inc. (NASDAQ:RTRX), New York, N.Y. Business: Renal, Musculoskeletal, Pulmonary Departed: Martin Shkreli as CEO Transitioned: Stephen Aselage, a director, to interim CEO from president and CO...